These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5500519)

  • 21. [Value of a new sulfonamide-biguanide association in the treatment of diabetes mellitus].
    Chon A
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):321-5. PubMed ID: 4679623
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral therapy for diabetes.
    Med J Aust; 1967 Nov; 2(20):909-10. PubMed ID: 5599936
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral differential therapy of diabetes mellitus].
    Mehnert H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
    [No Abstract]   [Full Text] [Related]  

  • 24. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
    Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
    Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
    [No Abstract]   [Full Text] [Related]  

  • 25. [The therapeutic efficacy of saccharoreducing preparation chlorcyclamide].
    Vorona MI; Genes SG; Grinchenko TS; Kopelovich MA; Lobanovskaia LI
    Klin Med (Mosk); 1968 Sep; 46(9):114-8. PubMed ID: 5715261
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of Daonil--a new sulphonylurea derivative].
    Nowotna-Walcowa R; Rozyńska E
    Pol Tyg Lek; 1971 Jan; 26(2):65-7. PubMed ID: 5101252
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical assessment of Gludiase in treatment of diabetes].
    Ponikowska I
    Pol Tyg Lek; 1971 May; 26(18):684-6. PubMed ID: 5090443
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 29. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 30. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
    Duncan LJ; Clarke BF; Munro JF
    Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
    [No Abstract]   [Full Text] [Related]  

  • 33. Secondary failure to sulphonylureas in the treatment of diabetes.
    S Afr Med J; 1967 May; 41(18):453-4. PubMed ID: 6028225
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with glybenclamide in 100 non-ketotic diabetics.
    Sahgal VK; Ahuja MM
    Indian J Med Res; 1971 Feb; 59(2):251-8. PubMed ID: 4931412
    [No Abstract]   [Full Text] [Related]  

  • 35. Glibenclamide for diabetes.
    Br Med J; 1971 Feb; 1(5747):473. PubMed ID: 5544009
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-therapeutic experiences with the new hypoglycemic sulfanylurea, glibenclamide].
    Arena D; Santeusanio F; Puxeddu A; De Ciuceis P; Migliorini E; Siracusa A; Brunetti P
    Clin Ter; 1970 Mar; 52(6):509-23. PubMed ID: 5452996
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience with glibenclamide.
    Galbraith HJ
    Postgrad Med J; 1970 Dec; ():Suppl:95-7. PubMed ID: 5533306
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of a new hypoglycemic sulfonamide: glibenclamide].
    Guinet P; Tourniaire J; Ollier C
    Rev Lyon Med; 1970 Oct; 19(16):655-64. PubMed ID: 5532152
    [No Abstract]   [Full Text] [Related]  

  • 39. Glibenclamide.
    Br Med J; 1971 Jun; 2(5762):644-5. PubMed ID: 5580727
    [No Abstract]   [Full Text] [Related]  

  • 40. [A comparative evaluation of the hypoglycemic activity of acetyl-alpha-carnitine and chlorpropamide in experimental diabetes].
    Kim EK; Trevisani K; Trevisani M; Suslina ZA; Seĭfulla RD
    Eksp Klin Farmakol; 1994; 57(4):52-3. PubMed ID: 7950787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.